英科医疗：子公司7000万美元参投170亿美元基金

Group 1 - The company plans to invest $70 million through its wholly-owned subsidiary, Inco Medical International Co., Ltd., in the Warburg Pincus Global Growth 15, L.P. fund [1][2] - The target fundraising size for the partnership is $17 billion [1][2] - This transaction is classified as a related party transaction but does not exceed 5% of the company's most recent audited net assets, thus it does not require shareholder approval [1][2] Group 2 - The investment aims to optimize the investment structure and enhance the global strategic layout of the company [1][2] - The company intends to leverage a specialized investment management team to improve its revenue levels and promote long-term strategic development [1][2]